Trade Kewaunee - KEQU CFD

Add to favourite

34.95

1.19%

View detailed chart

To be able to trade stocks like this, create an account and apply for a stock listing.

Create Account

Summary
Historical Data
Events
Income Statement
Balance Sheet
Cash Flow

Trading сonditions

Spread

0.75

Long position overnight fee

-0.026179%

Short position overnight fee

0.003957%

Overnight fee time

21:00 (UTC)

Min traded quantity

Currency

USD

Margin

Stock exchange

United States of America

Commission on trade

*Information provided by Capital.com

Key Stats

Prev. Close*	34.54
Open*	33.96
1-Year Change*	119.38%
Day's Range*	33.96 - 34.95
52 wk Range	14.56-30.30
Average Volume (10 days)	3,400.00
Average Volume (3 months)	80.75K
Market Cap	84.00M
P/E Ratio	12.28
Shares Outstanding	2.90M
Revenue	215.08M
EPS	2.36
Dividend (Yield %)	N/A
Beta	0.64
Next Earnings Date	Mar 6, 2024

All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com

Last Week
Last Month
Last Year
Last two Years
Max

Daily
Weekly
Monthly

Date	Close	Change	Change (%)	Open	High	Low
Apr 18, 2024	34.95	0.99	2.92%	33.96	35.05	33.96
Apr 17, 2024	34.54	-0.44	-1.26%	34.98	34.98	33.95
Apr 16, 2024	34.98	1.03	3.03%	33.95	35.63	33.53
Apr 15, 2024	34.14	0.19	0.56%	33.95	35.66	33.45
Apr 12, 2024	33.46	-1.14	-3.29%	34.60	34.60	33.08
Apr 11, 2024	33.86	-0.20	-0.59%	34.06	34.76	33.09
Apr 10, 2024	34.38	-0.32	-0.92%	34.70	35.15	34.06
Apr 9, 2024	34.06	0.23	0.68%	33.83	35.53	33.83
Apr 8, 2024	34.85	-0.74	-2.08%	35.59	35.59	33.28
Apr 5, 2024	35.62	0.03	0.08%	35.59	36.31	35.59
Apr 4, 2024	35.96	1.57	4.57%	34.39	36.34	34.39
Apr 3, 2024	34.80	0.46	1.34%	34.34	35.53	34.33
Apr 2, 2024	34.32	0.93	2.79%	33.39	34.75	33.39
Apr 1, 2024	34.34	0.39	1.15%	33.95	35.43	33.08
Mar 28, 2024	33.75	0.70	2.12%	33.05	34.39	33.05
Mar 27, 2024	32.71	-0.23	-0.70%	32.94	33.44	32.34
Mar 26, 2024	32.72	0.25	0.77%	32.47	33.24	32.34
Mar 25, 2024	32.73	0.67	2.09%	32.06	33.75	32.06
Mar 22, 2024	31.88	0.01	0.03%	31.87	32.17	31.44
Mar 21, 2024	31.73	-0.68	-2.10%	32.41	32.41	31.72

Kewaunee Events

Time (UTC)	Country	Event
Wednesday, June 26, 2024
Time (UTC) 10:59	Country US	Event Q4 2024 Kewaunee Scientific Corp Earnings Release Q4 2024 Kewaunee Scientific Corp Earnings Release Forecast - Previous -
Thursday, August 22, 2024
Time (UTC) 15:00	Country US	Event Kewaunee Scientific Corp Annual Shareholders Meeting Kewaunee Scientific Corp Annual Shareholders Meeting Forecast - Previous -
Thursday, August 29, 2024
Time (UTC) 10:59	Country US	Event Q1 2025 Kewaunee Scientific Corp Earnings Release Q1 2025 Kewaunee Scientific Corp Earnings Release Forecast - Previous -

View all events

Annual
Quarterly

	2023	2022	2021	2020	2019
Total revenue	219.494	168.872	147.469	147.54	146.55
Revenue	219.494	168.872	147.469	147.54	146.55
Cost of Revenue, Total	183.906	144.652	123.476	124.113	121.231
Gross Profit	35.588	24.22	23.993	23.427	25.319
Total Operating Expense	214.13	171.48	148.785	149.885	144.438
Other Operating Expenses, Total	30.224	26.828	25.309	25.772	23.207
Operating Income	5.364	-2.608	-1.316	-2.345	2.112
Interest Income (Expense), Net Non-Operating	-1.734	-0.632	-0.389	-0.493	-0.367
Other, Net	0.868	0.755	-0.912	-0.028	0.389
Net Income Before Taxes	4.498	-2.485	-2.617	-2.866	2.134
Net Income After Taxes	1.359	-6.003	-3.607	-4.624	1.763
Minority Interest	-0.621	-0.123	-0.065	-0.063	-0.159
Net Income Before Extra. Items	0.738	-6.126	-3.672	-4.687	1.604
Net Income	0.738	-6.126	-3.672	-4.687	1.529
Income Available to Common Excl. Extra. Items	0.738	-6.126	-3.672	-4.687	1.604
Income Available to Common Incl. Extra. Items	0.738	-6.126	-3.672	-4.687	1.529
Diluted Net Income	0.738	-6.126	-3.672	-4.687	1.529
Diluted Weighted Average Shares	2.902	2.786	2.76	2.75	2.794
Diluted EPS Excluding Extraordinary Items	0.25431	-2.19885	-1.33043	-1.70436	0.57409
Dividends per Share - Common Stock Primary Issue				0.38	0.74
Diluted Normalized EPS	0.25431	-2.19885	-1.33043	-1.70436	0.57409
Total Extraordinary Items					-0.075
Dilution Adjustment					0

	Jul 2023	Apr 2023	Jan 2023	Oct 2022	Jul 2022
Total revenue	49.839	53.986	60.821	54.564	50.123
Revenue	49.839	53.986	60.821	54.564	50.123
Cost of Revenue, Total	37.925	43.625	50.491	45.863	43.927
Gross Profit	11.914	10.361	10.33	8.701	6.196
Total Operating Expense	46.031	51.285	58.517	53.809	50.519
Other Operating Expenses, Total	8.106	7.66	8.026	7.946	6.592
Operating Income	3.808	2.701	2.304	0.755	-0.396
Interest Income (Expense), Net Non-Operating	-0.43	-0.544	-0.436	-0.37	-0.384
Other, Net	0.034	0.165	0.192	0.071	0.44
Net Income Before Taxes	3.412	2.322	2.06	0.456	-0.34
Net Income After Taxes	2.515	1.094	1.098	-0.114	-0.719
Minority Interest	-0.041	-0.089	-0.375	-0.129	-0.028
Net Income Before Extra. Items	2.474	1.005	0.723	-0.243	-0.747
Net Income	2.474	1.005	0.723	-0.243	-0.747
Income Available to Common Excl. Extra. Items	2.474	1.005	0.723	-0.243	-0.747
Income Available to Common Incl. Extra. Items	2.474	1.005	0.723	-0.243	-0.747
Diluted Net Income	2.474	1.005	0.723	-0.243	-0.747
Diluted Weighted Average Shares	2.885	3.142	2.911	2.83	2.807
Diluted EPS Excluding Extraordinary Items	0.85754	0.31986	0.24837	-0.08587	-0.26612
Diluted Normalized EPS	0.85754	0.31986	0.24837	-0.08587	-0.26612
Dividends per Share - Common Stock Primary Issue	0		0	0	0

Annual
Quarterly

	2023	2022	2021	2020	2019
Total Current Assets	87.92	91.565	60.457	54.231	65.357
Cash and Short Term Investments	8.078	4.433	5.206	4.365	10.647
Cash & Equivalents	8.078	4.433	5.206	4.365	10.647
Total Receivables, Net	46.081	54.711	35.05	28.062	33.259
Accounts Receivable - Trade, Net	46.081	54.711	34.095	28.062	33.259
Total Inventory	21.889	23.796	16.517	15.33	17.206
Prepaid Expenses	6.135	6.164	3.159	5.624	3.736
Other Current Assets, Total	5.737	2.461	0.525	0.85	0.509
Total Assets	118.898	118.773	89.384	83.929	87.223
Property/Plant/Equipment, Total - Net	25.572	22.694	25.261	25.584	16.462
Other Long Term Assets, Total	-3.881	3.221	3.666	4.114	5.404
Total Current Liabilities	40.053	42.293	34.181	27.06	32.733
Accounts Payable	23.599	27.316	16.78	13.114	15.19
Accrued Expenses	8.043	9.159	7.429	6.7	5.247
Notes Payable/Short Term Debt	3.587	1.588	6.828	4.719	9.513
Current Port. of LT Debt/Capital Leases	0.727	0.701	0.021	0.019	1.184
Other Current Liabilities, Total	4.097	3.529	3.123	2.508	1.599
Total Liabilities	81.489	83.079	48.143	45.514	40.123
Total Long Term Debt	28.28	29.003	0.091	0.113	0.229
Long Term Debt				0	0.229
Minority Interest	1.076	0.486	0.246	0.288	0.603
Other Liabilities, Total	11.137	10.869	13.318	17.652	6.558
Total Equity	37.409	35.694	41.241	38.415	47.1
Common Stock	7.084	6.983	6.915	6.885	6.875
Additional Paid-In Capital	5.059	4.483	3.807	3.36	3.133
Retained Earnings (Accumulated Deficit)	28.761	28.023	34.149	37.821	43.552
Treasury Stock - Common	-0.053	-0.053	-0.053	-0.053	-0.053
Other Equity, Total	-3.442	-3.742	-3.577	-9.598	-6.407
Total Liabilities & Shareholders’ Equity	118.898	118.773	89.384	83.929	87.223
Total Common Shares Outstanding	2.83	2.79	2.763	2.751	2.747
Property/Plant/Equipment, Total - Gross	70.538	67.899	68.083	67.171	56.676
Accumulated Depreciation, Total	-44.966	-45.205	-42.822	-41.587	-40.214
Capital Lease Obligations	28.28	29.003	0.091	0.113
Deferred Income Tax	0.943	0.428	0.307	0.401
Note Receivable - Long Term	9.287	1.293

	Jul 2023	Apr 2023	Jan 2023	Oct 2022	Jul 2022
Total Current Assets	93.52	87.92	91.561	90.614	97.783
Cash and Short Term Investments	12.699	8.078	13.047	9.419	14.36
Cash & Equivalents	12.699	8.078	13.047	9.419	14.36
Total Receivables, Net	42.461	46.081	43.988	41.472	40.714
Accounts Receivable - Trade, Net	42.461	46.081	43.988	41.472	40.714
Total Inventory	22.126	21.889	21.412	24.502	25.1
Prepaid Expenses	7.365	6.135	7.745	8.323	10.435
Other Current Assets, Total	8.869	5.737	5.369	6.898	7.174
Total Assets	124.818	118.898	121.786	119.118	125.643
Property/Plant/Equipment, Total - Net	25.951	25.572	24.104	24.515	23.741
Property/Plant/Equipment, Total - Gross	63.023	61.368	61.81	61.246	60.716
Accumulated Depreciation, Total	-45.684	-44.966	-47.269	-46.639	-45.93
Other Long Term Assets, Total	4.419	-3.881	4.747	2.36	2.447
Total Current Liabilities	44.229	40.053	44.213	42.858	49.517
Accounts Payable	22.14	23.599	24.914	23.05	25.042
Accrued Expenses	9.223	8.043	7.784	7.728	9.696
Notes Payable/Short Term Debt	5.054	3.587	5.753	0	0
Current Port. of LT Debt/Capital Leases	0.745	0.727	0.7	0.682	0.663
Other Current Liabilities, Total	7.067	4.097	5.062	11.398	14.116
Total Liabilities	85.388	81.489	86.435	84.716	90.957
Total Long Term Debt	28.101	28.28	28.454	28.678	28.842
Capital Lease Obligations	28.101	28.28	28.454	28.678	28.842
Deferred Income Tax	0.989	0.943	0.796	0.406	0.451
Minority Interest	1.11	1.076	0.987	0.607	0.497
Other Liabilities, Total	10.959	11.137	11.985	12.167	11.65
Total Equity	39.43	37.409	35.351	34.402	34.686
Common Stock	7.269	7.084	7.084	7.084	7.08
Additional Paid-In Capital	4.565	5.059	4.873	4.541	4.349
Retained Earnings (Accumulated Deficit)	31.235	28.761	27.756	27.033	27.276
Treasury Stock - Common	-0.053	-0.053	-0.053	-0.053	-0.053
Other Equity, Total	-3.586	-3.442	-4.309	-4.203	-3.966
Total Liabilities & Shareholders’ Equity	124.818	118.898	121.786	119.118	125.643
Total Common Shares Outstanding	2.904	2.83	2.83	2.83	2.829
Note Receivable - Long Term	0.928	9.287	1.374	1.629	1.672

Annual
Quarterly

	2022	2021	2020	2019	2018
Net income/Starting Line	-6.003	-3.607	-4.624	1.688	5.458
Cash From Operating Activities	-7.885	0.912	4.161	2.49	3.183
Cash From Operating Activities	2.769	2.687	2.654	2.571	2.761
Non-Cash Items	0.941	2.349	2.51	0.464	1.826
Cash Taxes Paid	1.006	1.8	0.188	2.46	2.872
Cash Interest Paid	0.48	0.065	0.513	0.352	0.295
Changes in Working Capital	-5.592	-0.517	3.621	-2.233	-6.862
Cash From Investing Activities	-1.908	-2.397	-2.465	-4.213	-3.395
Capital Expenditures	-1.908	-2.397	-2.465	-4.213	-3.395
Other Investing Cash Flow Items, Total
Cash From Financing Activities	11.031	1.982	-7.458	2.334	-2.484
Financing Cash Flow Items	0	-0.108	-0.324	-0.051	-0.074
Total Cash Dividends Paid		0	-1.044	-2.03	-1.794
Issuance (Retirement) of Stock, Net		0	-0.014	-0.036	0.008
Issuance (Retirement) of Debt, Net	11.031	2.09	-6.076	4.451	-0.624
Foreign Exchange Effects	-0.075	0.019	-0.179	-0.413	-0.287
Net Change in Cash	1.163	0.516	-5.941	0.198	-2.983

	Jan 2023	Oct 2022	Jul 2022	Apr 2022	Jan 2022
Net income/Starting Line	0.265	-0.833	-0.719	-6.003	-5.675
Cash From Operating Activities	-3.547	-0.586	3.685	-7.885	-1.087
Cash From Operating Activities	2.142	1.433	0.725	2.769	2.092
Non-Cash Items	0.778	0.36	0.218	0.941	0.529
Changes in Working Capital	-7.1	-1.524	3.461	-5.592	1.863
Cash From Investing Activities	-1.562	-0.919	-0.39	-1.908	-1.222
Capital Expenditures	-1.562	-0.919	-0.39	-1.908	-1.222
Cash From Financing Activities	17.089	11.525	11.67	11.031	2.119
Financing Cash Flow Items				0	0
Total Cash Dividends Paid
Issuance (Retirement) of Stock, Net					0
Issuance (Retirement) of Debt, Net	17.089	11.525	11.67	11.031	2.119
Foreign Exchange Effects	-0.458	-0.597	-0.325	-0.075	-0.039
Net Change in Cash	11.522	9.423	14.64	1.163	-0.229
Deferred Taxes	0.368	-0.022			0.104

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission

Leverage

1:1

20
100
500
1000
10000

Investment

Trade size (Leverage x Investement):

Open

Close

Short Long

For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

Kewaunee Company profile

About Kewaunee Scientific Corporation

Kewaunee Scientific Corporation is engaged in the designing, manufacturing, and installation of laboratory, healthcare, technical furniture and infrastructure products. The Company operates through two segments: Domestic, and International. The Company's Domestic business segment is engaged in designing, manufacturing, and installing scientific and technical furniture, including steel and wood laboratory cabinetry, fume hoods, laminate casework, flexible systems, worksurfaces, workstations, workbenches and computer enclosures. Its International business segment consists of foreign subsidiaries, such as Kewaunee Labway Asia Pte. Ltd., Kewaunee Scientific Corporation Singapore Pte. Ltd., Kewaunee Labway India Pvt. Ltd., and Koncepo Scientech International Pvt. Ltd., which provides the Company's products and services, including facility design, detailed engineering, construction, and project management from the planning stage through testing and commissioning of laboratories.

Financial summary

BRIEF: For the nine months ended 31 January 2022, Kewaunee Scientific Corporation revenues increased 10% to $119.2M. Net loss increased from $697K to $5.8M. Revenues reflect Domestic segment increase of 6% to $89.1M, International segment increase of 21% to $30M, Domestic segment increase of 6% to $89.1M, International segment increase of 21% to $30M. Higher net loss reflects Operating expenses increase of 6% to $19.7M (expense).

Equity composition

Common Stock $2.50 Par, 03/11, 5M auth., 2,578,270 o/s., net of shs. in Treas. @ Cost. Insiders & Strategic holders own 29.66%. Public Offering 2/68, 286,000 shares @ $25 by Glore Forgan & Wm.R. Stats.

Industry:

Business Support Supplies (NEC)

2700 W Front St
STATESVILLE
NORTH CAROLINA 28677
US

Income Statement

Annual
Quarterly

News

Gold price in 2024: geopolitical tensions and rate-cut expectations keep XAU/USD supported

Investors are keeping a close eye on gold as the conflict in the Middle East escalates with a possibility of a full-scale regional war in the area.

07:56, 17 April 2024

US Earnings Season : JP Morgan, Citigroup, Wells Fargo

The first major US banks report quarterly earnings on Friday, April 12th, 2024. We preview what to expect from JP Morgan, Citigroup, and Wells Fargo's quarterly numbers.

16:03, 11 April 2024

Reserve Bank of New Zealand Preview: Rates expected to remain on hold as inflation fight continues

The Reserve Bank of New Zealand (RBNZ) meets on Wednesday, April 10, 2024. We preview what to expect from the meeting and its possible impact on the NZD/USD.

09:22, 11 April 2024

US CPI Preview: US inflation expected to grind lower amid fears about sticky prices

US CPI data is released on Wednesday, 10 April. We preview what to expect from the data, how it could influence US Federal Reserve policy, and analyse the NASDAQ (US Tech 100).

15:11, 9 April 2024